- Home
- CTMX vs GNK Comparison
CTMX vs GNK Comparison
Compare CTMX & GNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTMX | GNK |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 977.1M | 967.7M |
| IPO Year | 2015 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CTMX | GNK |
|---|---|---|
| Price | $3.89 | $25.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | $12.10 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 3.4M | 256.9K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | $76,201,000.00 | ★ $342,054,000.00 |
| Revenue This Year | N/A | $21.15 |
| Revenue Next Year | $7.61 | $1.41 |
| P/E Ratio | ★ $22.58 | $119.81 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.72 | $12.66 |
| 52 Week High | $8.21 | $26.15 |
Technical Indicators
Market Signals| Indicator | CTMX | GNK |
|---|---|---|
| Relative Strength Index (RSI) | 36.51 | 63.86 |
| Support Level | $3.83 | $22.40 |
| Resistance Level | $3.91 | N/A |
| Average True Range (ATR) | 0.25 | 0.81 |
| MACD | -0.03 | 0.14 |
| Stochastic Oscillator | 3.96 | 90.20 |
Price Performance
Historical ComparisonAbout CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.